This is a synthetic peptide designed for use in combination with anti-BTLA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
BTLA
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
BTLA
(B and T Lymphocyte Associated (BTLA))
Synonyme
BTLA Peptide, BTLA1 Peptide, CD272 Peptide, A630002H24 Peptide, B and T lymphocyte associated Peptide, BTLA Peptide, Btla Peptide
Hintergrund
This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.
Alias Symbols: BTLA1, CD272, FLJ16065, MGC129743
Protein Interaction Partner: PTPN11,PTPN6,TNFRSF14,VTCN1,PTPN11